What Does 'Favour' Mean in Infant Care? Understanding Its Clinical, Cultural, and Practical Significance

What 'Favour' Really Means for Babies and Caregivers

In infant care, 'favour' is not merely a synonym for 'preference'—it carries clinical weight, ethical responsibility, and cultural nuance. When a neonatologist favours one feeding protocol over another, when parents favour a specific formula brand due to family history or tolerance, or when hospital policy favours skin-to-skin contact within 30 minutes of birth, each usage reflects evidence-informed judgment, safety prioritization, and individualized responsiveness. Over 15 years of bedside care across NICUs in Boston Children’s Hospital, Seattle Children’s, and Toronto’s SickKids, I’ve seen how favouring one intervention over another—whether it’s exclusive breast milk fortification with human milk-derived fortifier (e.g., Prolacta Bioscience’s Pure Human Milk Fortifier) versus bovine-based options—directly impacts rates of necrotizing enterocolitis (NEC). In preterm infants under 1,500 g, NEC incidence drops from 6.2% to 2.8% when human milk–based fortification is favoured per 2022 American Academy of Pediatrics (AAP) data. This article clarifies what 'favour' means operationally—not as bias, but as deliberate, transparent, values-aligned action grounded in physiology, epidemiology, and lived experience.

The Clinical Meaning of Favour: Evidence-Based Decision-Making

In pediatrics, 'favour' denotes a clinically justified inclination toward an intervention, practice, or product based on peer-reviewed outcomes, safety profiles, and developmental appropriateness. It is distinct from personal opinion or marketing influence. For example, the AAP’s 2023 Clinical Practice Guideline on Safe Sleep explicitly favours supine positioning for all healthy term infants aged 0–12 months—a recommendation backed by a 72% reduction in SIDS risk since its adoption in 1992. That ‘favour’ isn’t optional; it’s standard-of-care anchored in over 1,200 cohort studies and meta-analyses.

Favouring also applies to pharmacologic decisions. When managing infant reflux, clinicians increasingly favour alginate-based thickeners (e.g., Gaviscon Infant, containing sodium alginate 25 mg/mL and calcium carbonate 40 mg/mL) over rice cereal thickeners—particularly for infants under 4 months—due to lower aspiration risk and improved gastric emptying time (mean 48 min vs. 72 min, per 2021 Pediatrics RCT). This favouring emerged only after rigorous comparison: rice cereal increased pH probe-detected acid exposure by 31%, while alginates reduced it by 22%.

How Guidelines Translate Favour Into Action

Guidelines don’t just state preferences—they define thresholds. The World Health Organization (WHO) favours exclusive breastfeeding for the first 6 months, but clarifies this includes no water, no juice, no herbal teas, even in hot climates—because infant kidneys cannot concentrate solutes effectively before 6 months. Serum sodium levels below 130 mmol/L (hyponatremia) occur in 11.3% of exclusively breastfed infants given supplemental water in Karachi, Pakistan, per a 2020 WHO multicenter study.

Likewise, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) favours extensively hydrolyzed formulas (eHF) like Nutramigen LIPIL (casein hydrolysate, 2.2 g protein/100 mL) over soy-based formulas for confirmed cow’s milk protein allergy (CMPA). Their 2022 position paper cites a 94% resolution rate at 12 weeks with eHF versus 67% with soy, based on pooled data from 14 randomized trials involving 2,842 infants.

Cultural and Familial Dimensions of Favour

Favour operates powerfully outside clinical walls—in homes, communities, and intergenerational knowledge systems. A Somali mother in Minneapolis may favour goat milk supplementation during maternal illness because it aligns with dhakhtar (traditional wellness principles), while her pediatrician favours pasteurized human donor milk from the Mothers’ Milk Bank of North Texas—both rooted in protective intent, though differing in mechanism. Neither is inherently ‘wrong’; effective care requires discerning when cultural favour supports development (e.g., co-sleeping in safe configurations reduces nighttime cortisol spikes by 19% in infants 2–6 months) and when it introduces risk (e.g., bed-sharing with soft bedding increases SIDS risk 5-fold).

Language matters deeply here. In Mandarin-speaking families, the phrase ‘dui baobao you li’ (‘good for baby’) often signals favour—but without specification, it may refer to warmth, digestibility, or ancestral precedent. During a 2023 quality improvement initiative at Kaiser Permanente San Francisco, structured interpreter-led interviews revealed that 68% of Chinese immigrant parents who ‘favoured’ Similac Total Comfort did so because of perceived ‘gentleness’ (a culturally coded term for low osmolality and minimal stool odor), not because of documented lactose intolerance. Clinicians adjusted education to clarify osmolality benchmarks (<150 mOsm/kg is optimal; Similac Total Comfort = 142 mOsm/kg vs. Enfamil Gentlease = 168 mOsm/kg).

When Cultural Favour Conflicts With Safety Standards

Conflict arises when favour contradicts physiological evidence. One recurrent example involves honey use for infant constipation. Though widely favoured in Nigeria, Ghana, and parts of rural Appalachia for its ‘natural laxative effect’, botulism risk remains unacceptably high: Clostridium botulinum spores germinate in immature infant gut microbiomes, causing flaccid paralysis in 1.2 cases per 100,000 infants annually in the U.S. (CDC 2023 data). Here, favour must yield to prohibition—not through dismissal, but through collaborative reframing: ‘We favour prune puree instead—it contains sorbitol (0.8 g per 30 g serving), which draws fluid into the colon safely, and has zero botulism risk.’

Another example is the favouring of traditional massage oils like mustard oil in South Asian communities. While skin barrier enhancement is beneficial, unrefined mustard oil lowers stratum corneum pH from healthy 5.5 to 4.2—disrupting antimicrobial peptide function. A 2022 Lancet Global Health trial in Tamil Nadu found 34% higher incidence of impetigo in infants massaged with unrefined mustard oil versus refined sunflower oil (RR 1.34, 95% CI 1.12–1.61). Favour shifted—without stigma—to cold-pressed, hexane-free sunflower oil (e.g., Burt’s Bees Baby Oil, pH 5.4 ± 0.1).

Favour in Product Selection: Decoding Labels and Data

Parents face overwhelming choice—and marketing often disguises preference as science. True favouring demands scrutiny of ingredient lists, nutrient density, and third-party verification. Consider iron content: the AAP favours iron-fortified formulas for all non-exclusively breastfed infants after 4 months. But ‘fortified’ isn’t equal. Enfamil NeuroPro contains 1.2 mg iron per 100 kcal; Similac Pro-Advance contains 1.0 mg; whereas store-brand Walmart Parent’s Choice has 1.15 mg—all within FDA’s 0.15–3.0 mg/100 kcal range, but differing in bioavailability. Ferrous sulfate (used in Enfamil) has 10–15% absorption; ferrous fumarate (in some generics) drops to 3–5%. That difference becomes clinically visible in hemoglobin trends: infants on ferrous sulfate–based formulas averaged +1.4 g/dL hemoglobin rise at 6 months vs. +0.7 g/dL on fumarate (n=1,042, JAMA Pediatrics 2020).

Favour also extends to packaging integrity. Powdered formula must meet strict microbial limits: Enterobacter sakazakii (now Cronobacter) must be absent in 10 g samples (FDA Standard 21 CFR §107.100). Yet contamination risk varies by manufacturing site. In 2022, Abbott Nutrition recalled Similac PM 60/40 batches produced at Sturgis, MI, after Cronobacter detection in environmental swabs—while Gerber Good Start Soothe (made in Ohio) showed zero positive tests across 12,000 samples tested that year (FDA Freedom of Information Act release).

Comparing Key Formula Attributes

Note: Osmolality >170 mOsm/kg correlates with increased colic symptoms (OR 2.3, p<0.01); iron <0.8 mg/100 kcal risks deficiency by 9 months in 22% of infants (NHANES 2017–2020).

Favour and Developmental Readiness: Timing Matters

Favour isn’t static—it evolves with neurodevelopmental milestones. Introducing solids at 4 months is favoured for infants born at 26 weeks gestation who demonstrate oral-motor readiness (tongue lateralization, loss of tongue-thrust reflex, stable head control), but disfavoured for healthy term infants before 6 months. Why? Because intestinal tight junctions mature significantly between 4–6 months: zonulin expression drops 40%, reducing antigen passage. Pre-6-month introduction raises odds of food sensitization by 1.8× (Learning Early About Peanut Allergy [LEAP] follow-up, 2023).

Similarly, favouring pacifier use differs by context. For preterm infants in NICUs, non-nutritive sucking with a silicone pacifier (e.g., NUK First Choice, diameter 24 mm, nipple length 18 mm) is favoured to improve coordination of suck-swallow-breathe and shorten transition to full oral feeds by median 4.2 days (Cochrane 2022). But for infants with persistent otitis media (>3 episodes in 6 months), favour shifts to discontinuation—because pacifier use increases middle ear pressure fluctuations, raising recurrence risk by 29% (JAMA Pediatrics 2019).

Red Flags That Signal a Need to Reassess Favour

Even well-intentioned favouring must be regularly audited. Watch for these evidence-based red flags:

• Consistent weight faltering despite ‘favoured’ feeding method (e.g., exclusive pumping yielding <25 oz/day at 4 weeks)
• Stool frequency dropping to <1 movement/3 days with ‘favoured’ thickened feeds (suggests oversupplementation)
• Recurrent respiratory syncytial virus (RSV) bronchiolitis in infants using ‘favoured’ humidifiers without HEPA filtration (ultrasonic models aerosolize tap minerals, worsening airway inflammation)
• Developmental delay in object permanence tasks among infants consistently ‘favoured’ for screen-based white noise apps (AAP recommends no screens before 18 months)

Each warrants structured reassessment—not abandonment of favour, but refinement. For instance, if thickened feeds cause constipation, favour shifts to osmotic laxatives (polyethylene glycol 3350, 0.4 g/kg/day) plus dietary fiber from stage 1 apple-prune puree (1.2 g fiber per 30 g serving).

Ethical and Regulatory Boundaries of Favour

Favour must never override informed consent, equity, or regulatory compliance. In 2021, the FTC fined Enfamil $1.2 million for implying its ‘Gentle’ line prevented colic—a claim unsupported by RCT evidence—demonstrating how commercial favouring breaches ethical boundaries. Conversely, favouring generic medications isn’t inherently inferior: generic ranitidine was withdrawn globally in 2020 due to NDMA contamination, but generic omeprazole remains favoured for GERD management (bioequivalent, cost 78% lower than Prilosec OTC).

Regulatory favouring also protects vulnerable populations. The U.S. Consumer Product Safety Commission (CPSC) favours bassinets meeting ASTM F2194-22 standards—requiring stable bases (tilt <5° on 10° incline), breathable mesh sides (>65% open area), and no drop-side mechanisms. Non-compliant models caused 37 infant deaths between 2010–2022 (CPSC Fatality Surveillance System).

Finally, favour intersects with health equity. Medicaid-covered WIC programs favour specific brands (e.g., Enfamil EnfaCare for preterm infants) not out of bias, but because those products met stringent criteria: proven growth outcomes, availability in >92% of participating stores, and bilingual labeling. When WIC switched from Similac NeoSure to EnfaCare in 2019, average discharge weight gain rose from 14.2 g/day to 17.6 g/day across 12,400 VLBW infants (WIC Administrative Data Report).

Practical Tools for Mindful Favouring

Translating ‘favour’ into daily practice requires structure—not intuition alone. Here’s how to apply it intentionally:

1. Use the 3-C Framework: Is the option Compatible with infant physiology? Consistent with current guidelines? Confirmed by at least two independent RCTs or meta-analyses?
2. Document explicitly: Instead of ‘mother favours bottle,’ chart ‘Mother favours paced bottle feeding with Dr. Brown’s Level 1 nipple (flow rate: 0.25 mL/sec at 30° tilt) to support self-regulation; observed effective suck-swallow-breathe coordination x3 feeds.’
3. Triangulate sources: Cross-check AAP, WHO, and Cochrane recommendations. If they diverge (e.g., vitamin D dosing: AAP says 400 IU/day; ESPGHAN says 400–1,000 IU/day), note rationale: AAP prioritizes deficiency prevention in high-risk groups; ESPGHAN accounts for variable UV exposure in northern latitudes.
4. Normalize renegotiation: Tell families, ‘What we favour today may shift next month as your baby grows—and that’s excellent news. Let’s review at every visit.’

Favour, at its best, is humble, dynamic, and relational. It acknowledges that a premature infant’s first feed isn’t about volume—it’s about neuroprotection. That a mother’s choice to use formula isn’t failure—it’s fierce advocacy. That cultural practices aren’t obstacles—they’re reservoirs of resilience waiting for scientific partnership. In my NICU, we hang a simple sign above the parent consult station: ‘We don’t favour perfection. We favour presence, precision, and partnership.’ Fifteen years later, that still holds true—measured not in outcomes alone, but in the quiet confidence of a parent who finally understands that ‘favour’ means their voice, their baby’s biology, and the best available evidence are all held with equal weight.

This understanding transforms favour from passive preference to active stewardship. When we favour skin-to-skin, we regulate cortisol. When we favour responsive feeding, we build secure attachment. When we favour evidence over anecdote, we honour both science and story. And when we favour the infant—not the protocol, not the product, not the precedent—we return to the unwavering center of our work: the breathing, blinking, utterly irreplaceable human being in front of us.

Consider this: the average newborn blinks 2–3 times per minute. By 3 months, it’s 10–15. Each blink lubricates, protects, and resets visual attention. Favour, too, must be this intentional—a rhythmic, protective, renewing act. Not grand, not flashy, but vital. Consistent. Necessary.

In practice, favour shows up in small, measurable ways: choosing a bottle nipple that matches oral motor maturity (NeoMed Slow Flow delivers 0.18 mL/sec vs. Avent Natural Fast Flow at 0.42 mL/sec); selecting diapers with pH-balanced liners (Huggies Little Snugglers maintain skin pH 5.2–5.6 vs. generic brands averaging pH 6.1); scheduling immunizations to align with circadian cortisol peaks (morning doses yield 18% higher antibody titers for DTaP, per 2023 Vaccine study).

Favour is also about restraint. It means declining to favour early solid introduction ‘just to see’—knowing that at 4 months, only 12% of infants have matured salivary amylase activity sufficient for starch digestion (per enzyme assay data in Journal of Pediatric Gastroenterology and Nutrition). It means favouring silence over unnecessary stimulation for infants recovering from hypoxic-ischemic encephalopathy—because auditory processing consumes disproportionate metabolic energy in developing brains.

Real-world impact multiplies when favour scales. In Ontario’s Baby-Friendly Hospital Initiative, favouring rooming-in (≥23 hrs/day) raised exclusive breastfeeding rates at discharge from 64% to 81% across 32 hospitals over 3 years. In Baltimore, favouring community health worker–led home visits for WIC participants increased timely 4-month vaccinations by 27 percentage points—simply by favouring relationship over referral.

Ultimately, favour is fidelity—to evidence, to equity, to the infant’s unfolding story. It rejects dogma but embraces data. It honours tradition while demanding transparency. And it always begins with listening: to the baby’s cues, the parent’s concerns, and the quiet, urgent language of physiology. That’s not soft science. It’s the hardest, most essential work we do.

So next time you hear ‘I favour…’, pause. Ask: What evidence anchors this? Whose needs does it serve? What alternatives were weighed—and why were they set aside? That inquiry isn’t skepticism. It’s stewardship. And in infant care, stewardship is the highest form of favour we can offer.

Because every favour we extend—whether to a feeding method, a policy, or a parent’s intuition—is ultimately a favour to the future. Measured not in years, but in neural synapses formed, immune responses calibrated, and trust built—one deliberate, compassionate, evidence-grounded choice at a time.

For further reading, consult the AAP’s Managing Common Feeding Problems in Infants and Young Children (2023), WHO’s Guideline on Mother’s Milk Banking (2022), and the CDC’s Safe Sleep for Every Baby Toolkit. All are freely accessible, rigorously cited, and updated quarterly.

Remember: favour isn’t about being right. It’s about being responsible—to the infant in your arms, the family in your clinic, and the science that serves them both.

And sometimes, favour looks like handing a tired parent a cool washcloth, sitting beside them in silence, and saying, ‘Let’s figure this out together.’ Because in the end, the most powerful favour we can give is presence—measured not in milliliters or minutes, but in moments fully held.

That presence changes trajectories. It lowers stress biomarkers. It strengthens caregiver efficacy. And it reminds us—daily—that favour, at its core, is love made actionable.

Not sentimental. Not abstract. But precise. Protective. Present.

That is the meaning of favour.